Retention and excretion of manganese dioxide dispersions administered intravenously to humans. 1946

C W SHEPPARD, and P F HAHN

UI MeSH Term Description Entries
D008345 Manganese A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017895 Manganese Compounds Inorganic chemicals that contain manganese as an integral part of the molecule. Compounds, Manganese

Related Publications

C W SHEPPARD, and P F HAHN
January 1921, The Journal of experimental medicine,
C W SHEPPARD, and P F HAHN
June 1950, Lancet (London, England),
C W SHEPPARD, and P F HAHN
March 1970, Health physics,
C W SHEPPARD, and P F HAHN
August 1968, The Journal of nutrition,
C W SHEPPARD, and P F HAHN
December 1975, Archives of internal medicine,
C W SHEPPARD, and P F HAHN
February 1950, Archives of industrial hygiene and occupational medicine,
C W SHEPPARD, and P F HAHN
September 1991, Lipids,
Copied contents to your clipboard!